Erratum  by unknown
ERRATUMAn error appeared in the article “Cognitive Training for Attention-Deﬁcit/Hyperactivity Disorder: Meta-Analysis of Clinical
and Neuropsychological Outcomes From Randomized Controlled Trials” by Samuele Cortese, Maite Ferrin, Daniel Brandeis,
et al., published in the March 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry
(2015;54:164-174). On page 169, two of the 95% CIs reported in Table 2 contained typographical errors and were inaccurate.
The corrected data has been italicized in the table below. The errors do not change the ﬁndings of the paper. Nevertheless, to
be accurate, the corrected Table 2 appears below in its entirety. The authors and the editorial ofﬁce regret the error. &TABLE 2 Summary of Results Showing Pooled Standardized Mean Differences (SMD) Between Treatment and Control Arms for
Each Outcome
Outcome Trials Included Measure Study n
Effect Heterogeneity
SMD 95% CI p I2 p
ADHD total All MProx 14 0.37 0.09 to 0.66 .01 71 <.001
PBlind 11 0.20 0.01 to 0.40 .04 30 .16
Active control MProx 7 0.16 0.23 to 0.55 .41 71 <.001
PBlind 6 0.22 0.09 to 0.53 .17 42 .13
WMT MProx 6 0.00 0.31 to 0.31 1.00 56 .05
MPT MProx 5 0.79 0.46 to 1.12 <.001 36 .18
MED MProx 5 0.19 0.16 to 0.54 .30 56 .06
PBlind 5 0.11 0.10 to 0.32 .31 0 .74
Inattention All MProx 11 0.47 0.14 to 0.80 <.01 76 <.001
PBlind 9 0.32 0.01 to 0.66 .06 69 <.001
Active control MProx 5 0.30 0.17 to 0.76 .21 72 <.001
WMT MProx 5 0.22 0.18 to 0.62 .28 66 <.001
MED MProx 5 0.35 0.09 to 0.79 .29 71 .02
Hyper/Imp All MProx 9 0.14 0.07 to 0.35 .18 28 .28
PBlind 8 0.18 0.01 to 0.37 .06 0 .50
Active control MProx 5 0.01 0.25 to 0.22 .91 0 .60
WMT MProx 5 0.02 0.24 to 0.21 .89 0 .68
Executive function rating All MProx 6 0.35 0.08 to 0.61 .01 22 .22
Working memory (visual) All Objective 5 0.47 0.23 to 0.70 <.01 69 <.001
Active control Objective Insufﬁcient trials (n ¼ 4)
WMT Objective 5 0.47 0.23 to 0.70 <.01 69 <.001
Working memory (verbal) All Objective 8 0.52 0.24 to 0.80 <.01 48 .06
Active control Objective 5 0.58 0.23 to 0.94 .001 45 .12
WMT Objective 6 0.57 0.29 to 0.82 <.001 32 .19
Inhibition All Objective 6 0.07 0.15 to 0.28 .53 2 .4
Attention All Objective 7 0.14 0.19 to 0.48 .41 58 .03
Reading All Standardized tests 5 0.09 0.09 to 0.27 .33 23 .26
Arithmetic All Standardized tests 5 0.01 0.11 to 0.13 .84 0 .44
Note: The italicized data in the table indicates information corrected from the original published table. Significant effects are expressed in boldface. Table reports only
measures for which 5 or more trials were available. Where only most proximal rater (MProx) is reported, there were insufficient trials with probably blinded rater
(PBlind) measures. Active controls ¼ all trials with an active control arm such as easy or non-adaptive training; ADHD ¼ attention-deficit/hyperactivity disorder; All ¼ all
trials meeting inclusion criteria with available measure; MED ¼ trials in which <30% of participants were treated with ADHD medication; MPT ¼ multiple process
training; WMT ¼ all trials using just working memory training.
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